Development of a vaccine to prevent Japanese encephalitis: a brief review
- PMID: 20360904
- PMCID: PMC2840557
- DOI: 10.2147/ijgm.s6281
Development of a vaccine to prevent Japanese encephalitis: a brief review
Abstract
Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.
Keywords: Japanese encephalitis; concept; development; prevention; vaccine.
Similar articles
-
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®).J Prev Med Hyg. 2018 Mar 30;59(1):E99-E107. doi: 10.15167/2421-4248/jpmh2018.59.1.962. eCollection 2018 Mar. J Prev Med Hyg. 2018. PMID: 29938245 Free PMC article.
-
Travel-acquired Japanese encephalitis and vaccination considerations.J Infect Dev Ctries. 2015 Sep 27;9(9):917-24. doi: 10.3855/jidc.5108. J Infect Dev Ctries. 2015. PMID: 26409731 Review.
-
Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Mar 12;59(RR-1):1-27. MMWR Recomm Rep. 2010. PMID: 20224546
-
mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes.J Virol. 2017 Apr 28;91(10):e01348-16. doi: 10.1128/JVI.01348-16. Print 2017 May 15. J Virol. 2017. PMID: 28250133 Free PMC article.
-
Recent advances in Japanese encephalitis.F1000Res. 2017 Mar 13;6:259. doi: 10.12688/f1000research.9561.1. eCollection 2017. F1000Res. 2017. PMID: 28357054 Free PMC article. Review.
Cited by
-
Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA.J Virol. 2011 Nov;85(21):10976-88. doi: 10.1128/JVI.00846-11. Epub 2011 Aug 24. J Virol. 2011. PMID: 21865391 Free PMC article.
-
Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010.PLoS One. 2016 Jan 25;11(1):e0147841. doi: 10.1371/journal.pone.0147841. eCollection 2016. PLoS One. 2016. PMID: 26807709 Free PMC article.
-
Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus.Pharmaceuticals (Basel). 2019 Oct 16;12(4):157. doi: 10.3390/ph12040157. Pharmaceuticals (Basel). 2019. PMID: 31623241 Free PMC article. Review.
-
Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses.PLoS One. 2020 Oct 28;15(10):e0238609. doi: 10.1371/journal.pone.0238609. eCollection 2020. PLoS One. 2020. PMID: 33112881 Free PMC article.
References
-
- Wiwanitkit V. Japanese encephalitis. J Ped infect Dis. 2007;4(2):183–192.
-
- Halstead SB, Jacobson J. Japanese encephalitis. Adv Virus Res. 2003;61:103–138. - PubMed
-
- Watanabe T. Japanese encephalitis. Nippon Rinsho. 2003;61(Suppl 2):95–99. - PubMed
-
- Solomon T. Recent advances in Japanese encephalitis. J Neurovirol. 2003;9(2):274–283. - PubMed
-
- Kawakatsu S. Encephalitis and psychosis. Ryoikibetsu Shokogun Shirizu. 2003;(40):303–306. - PubMed
LinkOut - more resources
Full Text Sources